GCG and type 2 diabetes mellitus: Exendin-4 (Ex-4), a glucagon-like peptide-1 (GLP-1) analogue in treating T2D, is highly affinitive and specifically actives the GLP-1 receptor (GLP-1R) (Fehmann et al. 1994; Schepp et al. 1994).